Insights
More Articles
- WHO prequalifies Merck's Ebola vaccine
- France to maintain fast-tracks for drug trials
- NICE approves use of 2 of GW Pharma cannabis-based drugs for NHS use
- Lupin of India to sell Japanese unit for $526M
- Mylan's API manufacturing site in India gets FDA warning
WHO prequalifies Merck's Ebola vaccine
The World Health Organization has prequalified Merck's Ebola vaccine, VSV-EBOV, a day after the European Commission approved the treatment, which paves the way for groups such as Gavi, the Vaccine Alliance, and other agencies of the United Nations to stockpile and use the vaccine in at-risk countries. The vaccine is currently on compassionate use in the Democratic Republic of Congo as part of the preventive campaign to stall the spread of Ebola in the country. Center for Infectious Disease Research and Policy (11/12)
Read full article now.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!